Amouyal Philippe
SEC insider (Form 3/4/5 filer). CIK 0001376854. Director at CAVA GROUP, INC. (CAVA) and 1 other issuer. 8 reported Form 4/5 transactions since Sep 2024; latest on Jun 22, 2026. Located in THE WOODLANDS, TX.
Companies Amouyal Philippe has filed insider reports for
- CAVA GROUP, INC. (CAVA): Director
- LEXICON PHARMACEUTICALS, INC. (LXRX): Director
Amouyal Philippe
CIK: 0001376854
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Jun 22, 2026CAVA
CAVA GROUP, INC.
AwardDirect1.9K shares- - Jun 3, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
ExerciseDirect89.3K shares- - May 1, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
AwardDirectRestricted Stock Units
35.7K shares- - May 1, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
AwardDirectStock Option (Right to Buy)
43.5K shares- - Jun 20, 2025CAVA
CAVA GROUP, INC.
AwardDirect1.8K shares- - Jun 3, 2025LXRX
LEXICON PHARMACEUTICALS, INC.
AwardDirectStock Option (Right to Buy)
103.8K shares- - Jun 3, 2025LXRX
LEXICON PHARMACEUTICALS, INC.
AwardDirectRestricted Stock Units
89.3K shares- - May 13, 2025LXRX
LEXICON PHARMACEUTICALS, INC.
ExerciseDirect36.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 22, 2026 |  CAVA CAVA GROUP, INC. | Award | 1,881 | - | $0 | Direct |
| Jun 3, 2026 |  LXRX LEXICON PHARMACEUTICALS, INC. | Exercise | 89,312 | - | $0 | Direct |
| May 1, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Award Restricted Stock Units | 35,714 | - | - | Direct |
| May 1, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Award Stock Option (Right to Buy) | 43,478 | - | - | Direct |
| Jun 20, 2025 | CAVA CAVA GROUP, INC. | Award | 1,767 | - | - | Direct |
| Jun 3, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | Award Stock Option (Right to Buy) | 103,806 | - | - | Direct |
| Jun 3, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | Award Restricted Stock Units | 89,312 | - | - | Direct |
| May 13, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | Exercise | 36,810 | - | - | Direct |
1-8 of 8 transactions